Tetra Therapeutics
Shionogi Inc. is a subsidiary of Shionogi & Co., Ltd., managing clinical trials and research programs, including those formerly conducted by Tetra Discovery Partners, Inc. The company is involved in innovative research, including clinical trials for Fragile X Syndrome.
Industries
biotechnology
therapeutics
Nr. of Employees
small (1-50)
Products
Fragile X syndrome clinical trials
Active clinical study programs focused on Fragile X syndrome that are managed by the company's U.S. subsidiary.
Fragile X syndrome clinical trials
Active clinical study programs focused on Fragile X syndrome that are managed by the company's U.S. subsidiary.
Services
Clinical trial program management
Operational management and oversight of clinical trials and research programs by a U.S.-based subsidiary following an acquisition.
Clinical trial program management
Operational management and oversight of clinical trials and research programs by a U.S.-based subsidiary following an acquisition.
Expertise Areas
- Clinical trial management
- Rare disease clinical research (Fragile X syndrome)
- Post-acquisition program integration